Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIngenta Regulatory News (ING)

Share Price Information for Ingenta (ING)

Share Price is delayed by 15 minutes
Get Live Data
57.50    -4.00 (-6.50%)
Bid:
56.00
Ask:
59.00
Spread: 3.00 (5.357%)
Market Cap: £8.34m
ING Live PriceLast checked at - London Stock Exchange

Intraday Ingenta Share Chart

Trading Update

2 Feb 2023 07:00

RNS Number : 6547O
Ingenta PLC
02 February 2023
 

2 February 2023

 

Ingenta plc ("Ingenta" or the "Group")

Trading Update

Ingenta plc (AIM: ING), a leading software and services provider to the publishing and media industries, is pleased to provide the following trading update for the year ended 31 December 2022.

The Group expects to report revenue of approximately £10.45m (2021: £10.15m) and adjusted EBITDA of approximately £1.95m (2021: £1.45m), in line with market expectations. Closing year end cash balances were £2.4m (2021: £3.0m) after completion of the previously announced £2.07m tender offer in November 2022. Ingenta has no debt.

In line with the previously stated intention to implement a progressive dividend policy, the Board intends to pay a final dividend of 2.25 pence (2021: 2 pence) per ordinary share for the 2022 financial year, subject to shareholder approval at the 2023 AGM. The proposed final dividend timetable will be announced following the 2023 AGM.

The Group expects to announce its final results for the year ended 31 December 2022 in April 2023.

Scott Winner, Chief Executive Officer, commented:

"I'm pleased to report that in 2022 the Group delivered top line revenue growth combined with strong efficiency gains delivered in prior periods. This growth was generated primarily from our Commercial product division where we have had strong uptake of our consultancy and managed service offering.

On the new business front, we added three customers to our web-based digital content distribution platform and encouragingly, have also simplified the upgrade process for customers looking to migrate to more advanced SaaS-based solutions. Sales pipeline activity is encouraging, and we are actively looking to build on the revenue growth reported in 2022."

For further information contact:

 

Ingenta Plc Scott Winner, Chief Executive Officer

Jon Sheffield, Chief Financial Officer

+44 (0) 1865 397 800

 

Cenkos Securities plcKaty Birkin

Callum Davidson

 

+44 (0) 20 7397 8900

 

Certain of the information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK version of the EU Market Abuse Regulation (2014/596) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended and supplemented from time to time.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTVFLFBXLLFBBV
Date   Source Headline
5th Nov 20147:00 amRNSAppointment of Chief Technology Officer
16th Oct 20142:14 pmRNSHolding(s) in Company
22nd Sep 20147:00 amRNSTrading Statement
27th Aug 20147:00 amRNSContract Win
6th Aug 20147:00 amRNSInterim Results
19th Jun 20147:00 amRNSTrading Statement
28th Apr 20144:05 pmRNSPublication of report & accounts & Notice of AGM
11th Apr 20147:00 amRNSNew Contract Wins
19th Mar 20147:00 amRNSDirectorate Change
3rd Mar 20147:00 amRNSFinal Results
6th Jan 20143:11 pmRNSHolding(s) in Company
6th Dec 20134:16 pmRNSHolding(s) in Company
28th Nov 20137:00 amRNSTrading Update
14th Oct 20137:00 amRNSNew Contract Win
11th Oct 20133:49 pmRNSDirector/PDMR Shareholding
25th Sep 20135:48 pmRNSHolding(s) in Company
23rd Sep 20132:53 pmRNSHolding(s) in Company
30th Aug 20137:00 amRNSBeijing International Book Fair
29th Aug 201310:42 amRNSReplacement Director/PDMR Shareholding
27th Aug 20137:00 amRNSDirector/PDMR Shareholding
26th Jul 201312:32 pmRNSHolding(s) in Company
25th Jul 20137:00 amRNSHalf Yearly Report
21st Jun 20132:40 pmRNSHolding(s) in Company
21st Jun 20137:00 amRNSDirector/PDMR Shareholding
20th Jun 20137:00 amRNSDirector/PDMR Shareholding
15th Apr 20131:49 pmRNSNew contract wins
5th Apr 20134:19 pmRNSResult of AGM and Trading Update
11th Mar 20133:36 pmRNSReplacement - Publication of A/Cs & Notice of AGM
11th Mar 20138:06 amRNSPublication of Accounts and Notice of AGM
4th Mar 20137:00 amRNSFinal Results
24th Jan 20139:23 amRNSHolding(s) in Company
14th Jan 20137:42 amRNSTrading Update
18th Dec 20123:25 pmRNSHolding(s) in Company
7th Dec 20125:04 pmRNSHolding(s) in Company
1st Nov 20127:00 amRNSDirector/PDMR Shareholding
23rd Oct 201210:12 amRNSHolding(s) in Company
9th Oct 20124:09 pmRNSHolding(s) in Company
30th Aug 20124:02 pmRNSHolding(s) in Company
31st Jul 20127:00 amRNSHalf Yearly Report
23rd Apr 20123:09 pmRNSReport & Accounts and 2012 London Book Fair
11th Apr 201212:17 pmRNSHolding(s) in Company
10th Apr 20121:47 pmRNSDirector/PDMR Shareholding
28th Mar 20121:17 pmRNSHolding(s) in Company
9th Mar 201211:21 amRNSHolding(s) in Company
8th Mar 20125:56 pmRNSHolding(s) in Company
7th Mar 20126:24 pmRNSHolding(s) in Company
5th Mar 20127:00 amRNSPreliminary Results
16th Feb 201210:42 amRNSHolding(s) in Company
9th Feb 20126:03 pmRNSHolding(s) in Company
1st Feb 20127:00 amRNSChange of Name of Nominated Adviser and Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.